- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 211/42 - Oxygen atoms attached in position 3 or 5
Patent holdings for IPC class C07D 211/42
Total number of patents in this class: 161
10-year publication summary
|
16
|
17
|
13
|
13
|
10
|
11
|
13
|
10
|
16
|
0
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Prilenia Neurotherapeutics Ltd. | 83 |
8 |
| Genentech, Inc. | 3742 |
5 |
| Xenon Pharmaceuticals Inc. | 190 |
5 |
| Gen1e Lifesciences Inc. | 16 |
5 |
| Janssen Pharmaceutica N.V. | 3839 |
4 |
| Massachusetts Institute of Technology | 9795 |
4 |
| Theravance Biopharma R&D IP, LLC | 550 |
4 |
| Bristol-myers Squibb Company | 5080 |
3 |
| Bayer Pharma AG | 1096 |
3 |
| The Broad Institute, Inc. | 1584 |
3 |
| Oregon Health & Science University | 746 |
3 |
| Neophore Limited | 10 |
3 |
| F. Hoffmann-La Roche AG | 7958 |
2 |
| Bayer Cropscience AG | 2241 |
2 |
| FUJIFILM Corporation | 27102 |
2 |
| Takeda Pharmaceutical Company Limited | 2961 |
2 |
| ABA Chemicals Corporation | 24 |
2 |
| Amicus Therapeutics, Inc. | 341 |
2 |
| Chiesi Farmaceutici S.p.A. | 940 |
2 |
| Council of Scientific & Industrial Research | 1397 |
2 |
| Other owners | 95 |